
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHuman auditory perception and evaluation · Academic Publishing and Open Access · Transgenic Plants and Applications
Article title: Airway hyperresponsiveness to mannitol in relation to inspiratory and expiratory resistance in subjects with asthma, COPD, and healthy smokers
Authors: Abir Nasr, Georgia Papapostolou, Linnea Jarenbäck, Kerstin Romberg, Alf Tunsäter, Jaro Ankerst, Leif Bjermer and Ellen Tufvesson
Journal: European Clinical Respiratory Journal
Bibliometrics: Volume 12, Number 01, pages 1-12
DOI: https://doi.org/10.1080/20018525.2025.2546677
It has been noted by the authors that Tables 1 and 2 were not included in the originally published article. The correct Tables 1 and 2 are provided below, and the original article has been updated to include them.Table 1.Subject characteristics. AsthmaHealthynever-smokers COPDHealthy smoker n=239n=15p-value^e^n=25n=14p-value^f^p-value^g^Age, years49(34–58)47(34–66)0.6269(66–74)60(58–67)0.0043<0.0001Sex, females/males,n (%)127/112(53/47)8/7(53/47)0.9820/5(80/20)8/6(57/43)0.130.01Height, m1.73(1.67–1.80)1.74(1.69–1.81)0.861.65(1.61–1.72)1.70(1.67–1.79)0.0210.0002BMI, kg/m^2^25 (23–28)23 (22–25)0.1226 (24–29)26(22–31)0.570.18FeNO^a^, ppb19 (12-31)20 (15-24)0.8613(9-18)8 (6–12)0.040.0027Atopy^b^, n (%)148 (62)n.d.n.a.1 (4)0>0.99<0.0001Eosinophil^c^0.2 (0.10–0.3)0.1(0.1-0.15)0.0190.2 (0.2–0.4)0.1(0.1–0.2)0.00880.24Non-smoker/ex-smoker^d^/smoker, n157/8/7415/0/00.0211/17/70/2/120.001<0.001Packyears0(0–1)n. a.n.a26(13–39)38(30–48)0.061<0.0001Data is presented as median (IQR) if not otherwise stated.^a^FeNO was missing in 10 subjects (5 asthma, 1 healthy never-smoker, 3 COPD and 1 healthy smoker).^b^One missing phadiatop test (atopy) in COPD.^c^Eosinophil test was not performed in 8 subjects (1 asthma and 7 healthy never-smokers).^d^Ex-smokers were defined as former smokers with ≥ 5 pack-years of smoking history.^e^Comparison between asthma and healthy never-smokers.^f^Comparison between COPD and healthy smokers. ^g^Comparison between asthma and COPD.n. a.=non-applicable, BMI=body mass index, FeNO=fractional exhaled NO.Table 2.Correlations between the relative change in % from baseline to last dose in FEV_1_ (=Δ%FEV_1_) and in respiratory oscillometry indices (Δ%R5, Δ%R19 and Δ%X5) among subjects with negative and positive mannitol test. Δ%R5_insp_Δ%R5_exp_Δ%R19_insp_Δ%R19_exp_Δ%X5_insp_Δ%X5_exp_Asthma Neg. mannitol testr0.0490.120.0310.0200.0190.11 p0.540.130.700.800.820.18Pos. mannitol testr0.013-0.0160.10-0.044-0.12-0.044 p0.910.890.350.690.280.69COPD Neg. mannitol testr0.350.230.22-0.280.670.27 p0.270.470.500.380.020.39Pos. mannitol testr0.0280.460.170.240.380.44 p0.930.110.570.420.190.13Healthy Smokers Neg. mannitol testr0.570.11-0.14-0.250.32-0.50 p0.200.840.780.590.500.27Pos. mannitol testr-0.36**-0.82***-0.75***-0.82**-0.64-0.32 p0.440.0340.0660.0340.140.50r=Spearman´s rank correlation coefficient.
This correction does not affect the description, interpretation, or conclusions of the article.
